AC Immune SA
NASDAQ:ACIU
AC Immune SA
NASDAQ:ACIU
Price:
2.31 USD
-1.7%
Market Closed
Updated:
May 12, 2024
AC Immune SA
Other Operating Expenses
|
AC Immune SA
Other Operating Expenses Peer Comparison
Comparables:
ADCT
CRSP
BSLN
IDIA
KURN
Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
AC Immune SA
NASDAQ:ACIU
|
Other Operating Expenses
-CHf3.2m
|
CAGR 3-Years
19%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
ADC Therapeutics SA
NYSE:ADCT
|
Other Operating Expenses
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Other Operating Expenses
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Other Operating Expenses
CHf0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Idorsia Ltd
SIX:IDIA
|
Other Operating Expenses
-CHf1k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
Kuros Biosciences AG
SIX:KURN
|
Other Operating Expenses
-CHf6.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is AC Immune SA's Other Operating Expenses?
Other Operating Expenses
-3.2m
CHF
-3.2m
CHF
Based on the financial report for Dec 31, 2023, AC Immune SA's Other Operating Expenses amounts to -3.2m CHF.
What is AC Immune SA's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 5Y
8%
8%
Over the last year, the Other Operating Expenses growth was 34%. The average annual Other Operating Expenses growth rates for AC Immune SA have been 19% over the past three years , 8% over the past five years .
You don't have any saved screeners yet
